APP and Alzheimer disease: Specifically, amyloidogenic processing of APP and abnormal Aβ metabolism have been proposed to be two of the main causes of AD, supported by the mutations that cause increased Aβ production, in particular of the aggregation-prone Aβ42, leading to early-onset AD,6 whereas a mutation that lowers Aβ production has a preventive effect.7